2023 annual financial data
Cartesian Therapeutics 2023 Operating margin
Cartesian Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -332.32%.
Operating income was -86,416,000 USD and net income was -219,710,000 USD.
Operating cash flow was -51,161,000 USD.
Get free Cartesian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,004,000 USD
- Operating income
- -86,416,000 USD
- Net income
- -219,710,000 USD
- Operating cash flow
- -51,161,000 USD